<?xml version="1.0" ?>
<tv>
  <channel>
    <name>NHK World JP</name>
    <id>NHKWorld.jp</id>
    <title>Medical Frontiers</title>
    <desc>While immune checkpoint inhibitors can improve cancer survival rates, they only work in about 20 to 30 percent of patients. We interview Japanese researchers who are trying to overcome this challenge.</desc>
    <image>https://www3.nhk.or.jp/nhkworld/en/shows/2050160/images/wide_m_6yrQuoBoPoUiyD6P2MxdnieSgFeeB7X63km7Pjnb.jpg</image>
    <start>09:30PM</start>
    <finish>10:30PM</finish>
    <date>25 August 2025</date>
  </channel>
</tv>
